Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling

Oncogene volume 24, pages 8080–8084 (2005)Cite this article

Abstract

Disruption of components in the transforming growth factor-β (TGF-β) signalling cascade is a common occurrence in human cancers. TGF-β pathway activation is accomplished via serine/threonine kinase receptors and intracellular Smad transcription factors. A key regulatory step involves specific ubiquitination by Smurfs that mediate the proteasomal degradation of Smads and/or receptors. Here, we report a novel interaction between Smads and ubiquitin C-terminal hydrolase UCH37, a deubiquitinating enzyme that could potentially reverse Smurf-mediated ubiquitination. In GST pull down experiments, UCH37 bound weakly to Smad2 and Smad3 and bound very strongly to Smad7 in a region that is distinct from the –PY– motif in Smad7 that interacts with Smurf ubiquitin ligases. Endogenous Smad7 and UCH37 formed a stable complex in U4A/JAK1 cells and FLAG-Smad7 co-immunoprecipitated with HA-UCH37 in transfected HEK-293 cells. In addition, we show that UCH37 can deubiquitinate and stabilize the type I TGF-β receptor. Furthermore, overexpression of UCH37 upregulates TGF-β-dependent transcription and this effect is reversed in cells subject to RNAi-mediated knockdown of endogenous UCH37. These findings support a new role for deubiquitinating enzymes in the control of the TGF-β signalling pathway and provide a novel molecular target for the design of inhibitors with therapeutic potential in cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Chantry A . (1995). J. Biol. Chem., 270, 3068–3073.

  • Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T and Miyazono K . (2001). J. Biol. Chem., 276, 12477–12480.

  • Glickman MH and Ciechanover A . (2002). Physiol. Rev., 82, 373–428.

  • Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC and Rauscher III FJ . (1998). Oncogene, 16, 1097–1112.

  • Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH and Wrana JL . (2000). Mol. Cell., 6, 1365–1375.

  • Lam YA, DeMartino GN, Pickart CM and Cohen RE . (1997a). J. Biol. Chem., 272, 28438–28446.

  • Lam YA, Xu W, DeMartino GN and Cohen RE . (1997b). Nature, 385, 737–740.

  • Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J and Gu W . (2002). Nature, 416, 648–653.

  • Lo RS and Massague J . (1999). Nat. Cell Biol., 1, 472–478.

  • Shi Y and Massague J . (2003). Cell, 113, 685–700.

  • Suzuki C, Murakami G, Fukuchi M, Shimanuki T, Shikauchi Y, Imamura T and Miyazono K . (2002). J. Biol. Chem., 277, 39919–39925.

  • Ulloa L, Doody J and Massague J . (1999). Nature, 397, 710–713.

  • Wicks SJ, Lui S, Abdel-Wahab N, Mason RM and Chantry A . (2000). Mol. Cell. Biol., 20, 8103–8111.

  • Wing SS . (2003). Int. J. Biochem. Cell Biol., 35, 590–605.

  • Zhu H, Kavsak P, Abdollah S, Wrana JL and Thomsen GH . (1999). Nature, 400, 687–693.

Download references

Acknowledgements

This study was supported by research grants from the BBSRC (AC), Wellcome Trust, UK (AC), NIH Grant R01 GM37666 (REC) and the Dutch Cancer Society (PTD). We thank Caroline Hill, Takeshi Imamura, Ian Kerr and Ana Costa-Pereira for vectors and cell lines. We also thank the Nederlands Kanker Instituut (NKI) and Cancer Research UK for allowing us to use the RNAi-UCH37 construct.

Author information

Authors and Affiliations

  1. School of Biological Sciences, University of East Anglia, Earlham Road, Norwich, NR4 7TJ, Norfolk, UK

    Stephen J Wicks, Katherine Haros, Marjorie Maillard & Andrew Chantry

  2. Department of Biochemistry, University of Iowa, Bowen Science Building, 51 Newton Road, Iowa City, 52242-1109, IA, USA

    Ling Song & Robert E Cohen

  3. Department of Molecular Cell Biology, Leiden University Medical Center, Div. 5, Wassenaarseweg 72, Leiden, 2333, AL, The Netherlands

    Peter ten Dijke

Authors
  1. Stephen J Wicks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katherine Haros
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marjorie Maillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ling Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert E Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter ten Dijke
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrew Chantry
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wicks, S., Haros, K., Maillard, M. et al. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling. Oncogene 24, 8080–8084 (2005). https://doi.org/10.1038/sj.onc.1208944

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208944

Keywords

This article is cited by

Search

Advanced search

Quick links